Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.

Reset all filters
01 1Sichuan Qingmu Pharmaceutical
02 1Piramal Pharma Solutions
03 1Blank
Reset all filters
01 1China
02 1U.S.A
03 1Blank
Reset all filters
01 3Blank
01 3Blank
Reset all filters
01 3Blank
Reset all filters
01 3Blank
Reset all filters
01 3Blank
Reset all filters
01 143076-010
02 158621-006
03 1Blank
01 3Blank
NDC Package Code : 58621-006
Start Marketing Date : 2017-04-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (16.4mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
NDC Package Code : 43076-010
Start Marketing Date : 2018-01-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
We have 2 companies offering Rabacfosadine
Get in contact with the supplier of your choice: